김상건 교수 연구실
연구실 정보 수정하기
홈
기본 정보
연구 영역
프로젝트
발행물
구성원
발행물
논문
저서
컨퍼런스
전체 논문
349
필터 설정하기
71
DA6034 promotes gastric epithelial cell migration and wound-healing through the mTOR pathway
김상건, 김영우, 이우형, 최슬민, 서윤영, 안병옥, 김순회
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2012
72
Hemin, an iron-binding porphyrin, inhibits HIF-1 alpha induction through its binding with heat shock protein 90
김상건, 이정민, 이우형, 계희연, 김은숙, 문애리
INTERNATIONAL JOURNAL OF CANCER, 2012
73
Rimonabant, a CB1 Inverse Agonist, Inhibits Hepatocyte Lipogenesis by Activating LKB1 and AMPK Axis Downstream of G{alpha}i/o Inhibition.
김상건, Wu Hong Min, 양윤미
MOLECULAR PHARMACOLOGY, 2011
74
Nrf2-mediated liver protection by sauchinone, an antioxidant lignan, from acetaminophen toxicity through the PKCdelta-GSK3beta pathway.
김상건, 계희연, 김영우, 류다혜, 성상현, 황세진
BRITISH JOURNAL OF PHARMACOLOGY, 2011
75
FXR activation by chenodeoxycholic acid induces detoxifying enzymes through AMPK and ERK1/2-mediated phosphorylation of C/EBPbeta
김상건, 노경, 김영미, 김영우
DRUG METABOLISM AND DISPOSITION, 2011
76
Sphingosine 1-phosphate regulates matrix metalloproteinase-9 expression and breast cell invasion through S1P3-G{alpha}q coupling.
김은숙, 김종숙, 김상건, 황세진, 이창호, 문애리
JOURNAL OF CELL SCIENCE, 2011
77
Toll-like receptor modulators: a patent review (2006-2010)
김상건, Shaherin Basith, Balachandran Manavalan, 이지왕, 최상돈
EXPERT OPINION ON THERAPEUTIC PATENTS, 2011
78
Nrf2 Inhibits LXRalpha-Dependent Hepatic Lipogenesis by Competing with FXR for Acetylase Binding.
김상건, 계희연, 김원동, 황세진, 최흥식, Gilroy RK, Wan YJ
ANTIOXIDANTS & REDOX SIGNALING, 2011
79
Oltipraz therapy in patients with liver fibrosis or cirrhosis: a randomized, double-blind, placebo-controlled phase II trial
김상건, 김영미, 최종영, 한준열, 장정원, 조세현, 엄순호, 천채윤, 이동후, 장자준, 유은실, 이용석
JOURNAL OF PHARMACY AND PHARMACOLOGY, 2011
80
Phenethyl Isothiocyanate Inhibits 12-O-Tetradecanoylphorbol-13-Acetate-Induced Inflammatory Responses in Mouse Skin
이여명, 조한진, Shree Priya Ponnuraj, 김종대, 김종상, 박정한윤, 김상건
JOURNAL OF MEDICINAL FOOD, 2011
1
2
3
4
5
6
7
8
9
10